A detailed history of Fortis Group Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 2,614 shares of LLY stock, worth $2.46 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
2,614
Previous 400 553.5%
Holding current value
$2.46 Million
Previous $233 Million 772.16%
% of portfolio
0.37%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $1.31 Million - $1.75 Million
2,214 Added 553.5%
2,614 $2.03 Billion
Q4 2023

Mar 04, 2024

BUY
$525.19 - $619.13 $105,038 - $123,826
200 Added 100.0%
400 $233 Million
Q3 2023

Dec 01, 2023

BUY
$434.7 - $599.3 $86,940 - $119,859
200 New
200 $107 Million
Q1 2023

May 26, 2023

SELL
$310.63 - $364.82 $1 Million - $1.18 Million
-3,221 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$146.22 - $169.13 $470,974 - $544,767
3,221 New
3,221 $476,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $893B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.